371 related articles for article (PubMed ID: 25006241)
1. Invasive aspergillosis caused by Aspergillus terreus: an emerging opportunistic infection with poor outcome independent of azole therapy.
Hachem R; Gomes MZ; El Helou G; El Zakhem A; Kassis C; Ramos E; Jiang Y; Chaftari AM; Raad II
J Antimicrob Chemother; 2014 Nov; 69(11):3148-55. PubMed ID: 25006241
[TBL] [Abstract][Full Text] [Related]
2. Aspergillus terreus: an emerging amphotericin B-resistant opportunistic mold in patients with hematologic malignancies.
Hachem RY; Kontoyiannis DP; Boktour MR; Afif C; Cooksley C; Bodey GP; Chatzinikolaou I; Perego C; Kantarjian HM; Raad II
Cancer; 2004 Oct; 101(7):1594-600. PubMed ID: 15378491
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology and outcome of infections due to Aspergillus terreus: 10-year single centre experience.
Lass-Flörl C; Griff K; Mayr A; Petzer A; Gastl G; Bonatti H; Freund M; Kropshofer G; Dierich MP; Nachbaur D
Br J Haematol; 2005 Oct; 131(2):201-7. PubMed ID: 16197450
[TBL] [Abstract][Full Text] [Related]
4. Amphotericin B lipid complex versus liposomal amphotericin B monotherapy for invasive aspergillosis in patients with hematologic malignancy.
Hachem RY; Boktour MR; Hanna HA; Husni RN; Torres HA; Afif C; Kontoyiannis DP; Raad II
Cancer; 2008 Mar; 112(6):1282-7. PubMed ID: 18224662
[TBL] [Abstract][Full Text] [Related]
5. Outcome analysis of invasive aspergillosis in hematologic malignancy and hematopoietic stem cell transplant patients: the role of novel antimold azoles.
Ramos ER; Jiang Y; Hachem R; Kassis C; Kontoyiannis DP; Raad I
Oncologist; 2011; 16(7):1049-60. PubMed ID: 21659609
[TBL] [Abstract][Full Text] [Related]
6. Itraconazole added to a lipid formulation of amphotericin B does not improve outcome of primary treatment of invasive aspergillosis.
Kontoyiannis DP; Boktour M; Hanna H; Torres HA; Hachem R; Raad II
Cancer; 2005 Jun; 103(11):2334-7. PubMed ID: 15844093
[TBL] [Abstract][Full Text] [Related]
7. Low prevalence of resistance to azoles in Aspergillus fumigatus in a French cohort of patients treated for haematological malignancies.
Alanio A; Sitterlé E; Liance M; Farrugia C; Foulet F; Botterel F; Hicheri Y; Cordonnier C; Costa JM; Bretagne S
J Antimicrob Chemother; 2011 Feb; 66(2):371-4. PubMed ID: 21131690
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for pulmonary Aspergillus terreus infection in patients with positive culture for filamentous fungi.
Castón JJ; Linares MJ; Gallego C; Rivero A; Font P; Solís F; Casal M; Torre-Cisneros J
Chest; 2007 Jan; 131(1):230-6. PubMed ID: 17218581
[TBL] [Abstract][Full Text] [Related]
9. Clinical epidemiology of 960 patients with invasive aspergillosis from the PATH Alliance registry.
Steinbach WJ; Marr KA; Anaissie EJ; Azie N; Quan SP; Meier-Kriesche HU; Apewokin S; Horn DL
J Infect; 2012 Nov; 65(5):453-64. PubMed ID: 22898389
[TBL] [Abstract][Full Text] [Related]
10. Azole resistance in Aspergillus fumigatus: a new challenge in the management of invasive aspergillosis?
Snelders E; Melchers WJ; Verweij PE
Future Microbiol; 2011 Mar; 6(3):335-47. PubMed ID: 21449843
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology of invasive aspergillosis and azole resistance in patients with acute leukaemia: the SEPIA Study.
Koehler P; Hamprecht A; Bader O; Bekeredjian-Ding I; Buchheidt D; Doelken G; Elias J; Haase G; Hahn-Ast C; Karthaus M; Kekulé A; Keller P; Kiehl M; Krause SW; Krämer C; Neumann S; Rohde H; La Rosée P; Ruhnke M; Schafhausen P; Schalk E; Schulz K; Schwartz S; Silling G; Staib P; Ullmann A; Vergoulidou M; Weber T; Cornely OA; Vehreschild MJ
Int J Antimicrob Agents; 2017 Feb; 49(2):218-223. PubMed ID: 27989379
[TBL] [Abstract][Full Text] [Related]
12. Treating invasive aspergillosis in patients with hematologic malignancy: diagnostic-driven approach versus empiric therapies.
Dib RW; Hachem RY; Chaftari AM; Ghaly F; Jiang Y; Raad I
BMC Infect Dis; 2018 Dec; 18(1):656. PubMed ID: 30545320
[TBL] [Abstract][Full Text] [Related]
13. Nationwide Surveillance of Azole Resistance in Aspergillus Diseases.
Vermeulen E; Maertens J; De Bel A; Nulens E; Boelens J; Surmont I; Mertens A; Boel A; Lagrou K
Antimicrob Agents Chemother; 2015 Aug; 59(8):4569-76. PubMed ID: 25987612
[TBL] [Abstract][Full Text] [Related]
14. Infections due to Aspergillus terreus: a multicenter retrospective analysis of 83 cases.
Steinbach WJ; Benjamin DK; Kontoyiannis DP; Perfect JR; Lutsar I; Marr KA; Lionakis MS; Torres HA; Jafri H; Walsh TJ
Clin Infect Dis; 2004 Jul; 39(2):192-8. PubMed ID: 15307028
[TBL] [Abstract][Full Text] [Related]
15. Invasive aspergillosis in a tertiary-care hospital in Thailand.
Kiertiburanakul S; Thibbadee C; Santanirand P
J Med Assoc Thai; 2007 May; 90(5):895-902. PubMed ID: 17596043
[TBL] [Abstract][Full Text] [Related]
16. [Guideline based treatment of invasive aspergillosis].
Karthaus M
Mycoses; 2010 May; 53 Suppl 1():36-43. PubMed ID: 20433655
[TBL] [Abstract][Full Text] [Related]
17. Increasing incidence of invasive aspergillosis in pediatric hematology oncology patients over the last decade: a retrospective single centre study.
Rubio PM; Sevilla J; González-Vicent M; Lassaletta A; Cuenca-Estrella M; Díaz MA; Riesco S; Madero L
J Pediatr Hematol Oncol; 2009 Sep; 31(9):642-6. PubMed ID: 19684521
[TBL] [Abstract][Full Text] [Related]
18. Therapy with antifungals decreases the diagnostic performance of PCR for diagnosing invasive aspergillosis in bronchoalveolar lavage samples of patients with haematological malignancies.
Reinwald M; Hummel M; Kovalevskaya E; Spiess B; Heinz WJ; Vehreschild JJ; Schultheis B; Krause SW; Claus B; Suedhoff T; Schwerdtfeger R; Reuter S; Kiehl MG; Hofmann WK; Buchheidt D
J Antimicrob Chemother; 2012 Sep; 67(9):2260-7. PubMed ID: 22740590
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and molecular characterization of azole resistance in Aspergillus spp. isolates from German cystic fibrosis patients.
Fischer J; van Koningsbruggen-Rietschel S; Rietschel E; Vehreschild MJ; Wisplinghoff H; Krönke M; Hamprecht A
J Antimicrob Chemother; 2014 Jun; 69(6):1533-6. PubMed ID: 24486872
[TBL] [Abstract][Full Text] [Related]
20. Environmental and clinical epidemiology of Aspergillus terreus: data from a prospective surveillance study.
Rüping MJ; Gerlach S; Fischer G; Lass-Flörl C; Hellmich M; Vehreschild JJ; Cornely OA
J Hosp Infect; 2011 Jul; 78(3):226-30. PubMed ID: 21440331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
